.avif)
TP53 Gene Test - Leukaemia Biomarker
The TP53 gene test screens for inherited mutations in the TP53 tumor‑suppressor gene that cause Li‑Fraumeni syndrome and greatly increase lifetime risk of multiple cancers, especially early‑onset breast cancer, sarcomas, brain tumors, adrenocortical carcinoma, and certain leukemias. Knowing your TP53 status can enable earlier, more intensive screening and preventive actions for you and at‑risk relatives, potentially improving early detection and risk management.
BCR-ABL Gene Test - Leukaemia Biomarker
A BCR‑ABL gene test detects the Philadelphia chromosome fusion to diagnose and monitor blood cancers (notably chronic myeloid leukemia and some acute leukemias). Early detection and ongoing monitoring guide targeted treatment decisions and help prevent disease progression, complications, and relapse.
.svg)
